on 190 patients recruited in eight European centers (16) that did not demonstrate any adverse outcome for hyperglycemia or arterial hypertension in acromegalic patients with discordant GH/IGF-1 values, either in High GH or in High IGF-1 patients. This evidence concerns the gene IGF1 and Hypertension.